Indeed, other studies using more reliable peptide-MHC tetramer staining have reported higher frequencies tumour-specific T cells in the MC38 model, with Dpagt1-specific CD8+ T cells composing over 20% of CD8+ TILs in D13 tumours (97). This evidence concerns the gene CD8A and neoplasm.